ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2018

Dec 15, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2018-12-13

Reporting Person: SOUTHWELL DAVID P (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-13	Common Stock	S	38768	$15.19	Disposed	95160	Direct

Footnotes

F1: The reported sales were made for the sole purpose of fulfilling the reporting person's tax obligations in connection with the settlement of restricted stock units.

F2: This transaction was executed in multiple trades at prices ranging from $15.00 to $15.80. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.